Metabolic therapy developer Axcella Health has priced its shares at $20 each in an offering that enabled Nestlé Health Science to exit.

Arange of financial services firms, payment processors and fintech providers are set to exit the electronic billing software producer in an acquisition by Mastercard.

The immunotherapy developer, which is exploits Yale University research and counts Eli Lilly, Pfizer, Taiho and Ping An as investors, floated in the middle of its range after raising $160m in venture funding.

The immunotherapy developer, which counts Eli Lilly, Pfizer, Taiho and Ping An as investors, floated in the middle of its range after raising $160m in venture funding.

Lundbeck-backed pruritus therapy developer Trevi Therapeutics raised $55m when it floated, but had to price its shares significantly below its range.

Intel Capital and Wipro Ventures have exited machine learning-based data management platform Imanis Data, which has been bought by Cohesity.

Edgewell Personal Care has agreed to acquire razor subscription service Harry’s in a cash and stock transaction that will allow Grace Beauty Capital to exit.

SoftBank Vision Fund is selling $245m of shares while PayPal is investing $500m in the ride hailing service, in the world's largest IPO since 2014.

Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.

Pfizer, Takeda and Alphabet-backed degenerative disease drug developer Cortexyme priced its initial public offering in the middle of its range to raise $75m.